Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
improves	O
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
but	O
induces	O
liver	O
steatosis	I:C0015695
in	O
high	O
-	I:C0026809
fat	I:C0026809
-	I:C0026809
diet	I:C0026809
mice	I:C0026809
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
improves	B:C0184511
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
but	O
induces	O
liver	O
steatosis	I:C0015695
in	O
high	O
-	I:C0026809
fat	I:C0026809
-	I:C0026809
diet	I:C0026809
mice	I:C0026809
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
improves	O
glucose	O
tolerance	O
and	O
insulin	B:C0021655
resistance	I:C0021655
but	O
induces	O
liver	O
steatosis	I:C0015695
in	O
high	O
-	I:C0026809
fat	I:C0026809
-	I:C0026809
diet	I:C0026809
mice	I:C0026809
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
improves	O
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
but	O
induces	O
liver	B:C0015695
steatosis	I:C0015695
in	O
high	O
-	I:C0026809
fat	I:C0026809
-	I:C0026809
diet	I:C0026809
mice	I:C0026809
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
improves	O
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
but	O
induces	O
liver	O
steatosis	I:C0015695
in	O
high	B:C0026809
-	I:C0026809
fat	I:C0026809
-	I:C0026809
diet	I:C0026809
mice	I:C0026809
.	O

Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	O
protein	I:C0033684
predominantly	O
expressed	O
in	O
liver	O
and	O
adipose	O
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	O
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	O
protein	I:C0033684
predominantly	O
expressed	O
in	O
liver	O
and	O
adipose	O
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	O
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	B:C0033684
protein	I:C0033684
predominantly	O
expressed	O
in	O
liver	O
and	O
adipose	O
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	O
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	O
protein	I:C0033684
predominantly	O
expressed	B:C1171362
in	O
liver	O
and	O
adipose	O
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	O
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	O
protein	I:C0033684
predominantly	O
expressed	O
in	O
liver	B:C0736268
and	O
adipose	O
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	O
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	O
protein	I:C0033684
predominantly	O
expressed	O
in	O
liver	O
and	O
adipose	B:C0001527
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	O
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
(	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
)	O
is	O
a	O
secreted	O
protein	I:C0033684
predominantly	O
expressed	O
in	O
liver	O
and	O
adipose	O
tissues	I:C0001527
,	O
and	O
has	O
been	O
identified	O
as	O
an	O
adipokine	B:C1955907
.	O

Angiopoietin	B:C1423931
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	B:C0017337
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	B:C0166418
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	B:C0003367
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	B:C1875327
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	B:C2603343
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	B:C0206131
lipolysis	O
.	O

Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
is	O
the	O
target	O
gene	O
of	O
peroxisome	O
proliferator	I:C0166418
‑activated	I:C0166418
receptors	I:C0166418
,	O
which	O
are	O
widely	O
used	O
as	O
lipid‑lowering	O
and	O
anti‑diabetic	O
drugs	I:C1875327
,	O
and	O
previous	O
studies	O
have	O
demonstrated	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
is	O
able	O
to	O
directly	O
stimulate	O
adipocyte	O
lipolysis	B:C0023796
.	O

The	O
current	O
study	B:C2603343
focused	O
on	O
how	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
was	O
involved	O
in	O
regulating	O
lipid	I:C1158445
and	O
glucose	O
metabolism	I:C2612213
in	O
high	O
‑fat‑diet	I:C0025929
(	I:C0025929
HFD	I:C0025929
)	I:C0025929
C57	I:C0025929
mice	I:C0025929
.	O

The	O
current	O
study	O
focused	O
on	O
how	O
Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
was	O
involved	O
in	O
regulating	O
lipid	I:C1158445
and	O
glucose	O
metabolism	I:C2612213
in	O
high	O
‑fat‑diet	I:C0025929
(	I:C0025929
HFD	I:C0025929
)	I:C0025929
C57	I:C0025929
mice	I:C0025929
.	O

The	O
current	O
study	O
focused	O
on	O
how	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
was	O
involved	O
in	O
regulating	B:C1158445
lipid	I:C1158445
and	O
glucose	O
metabolism	I:C2612213
in	O
high	O
‑fat‑diet	I:C0025929
(	I:C0025929
HFD	I:C0025929
)	I:C0025929
C57	I:C0025929
mice	I:C0025929
.	O

The	O
current	O
study	O
focused	O
on	O
how	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
was	O
involved	O
in	O
regulating	O
lipid	I:C1158445
and	O
glucose	B:C2612213
metabolism	I:C2612213
in	O
high	O
‑fat‑diet	I:C0025929
(	I:C0025929
HFD	I:C0025929
)	I:C0025929
C57	I:C0025929
mice	I:C0025929
.	O

The	O
current	O
study	O
focused	O
on	O
how	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
was	O
involved	O
in	O
regulating	O
lipid	I:C1158445
and	O
glucose	O
metabolism	I:C2612213
in	O
high	B:C0025929
‑fat‑diet	I:C0025929
(	I:C0025929
HFD	I:C0025929
)	I:C0025929
C57	I:C0025929
mice	I:C0025929
.	O

In	O
the	O
present	O
study	B:C2603343
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	B:C0025929
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	B:C0025929
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	B:C0001483
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	B:C0001483
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	B:C0025929
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	B:C0001483
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	B:C1423931
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

In	O
the	O
present	O
study	O
,	O
mice	O
were	O
divided	O
into	O
three	O
groups	O
,	O
with	O
standard	O
chow	O
mice	I:C0025929
as	O
a	O
normal	O
control	O
,	O
adenovirus	O
(	O
adenovirus	O
)	O
‑	O
injected	O
HFD	I:C0025929
mice	I:C0025929
as	O
a	O
model	O
control	O
and	O
adenovirus	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
‑	O
injected	B:C0025929
HFD	I:C0025929
mice	I:C0025929
as	O
the	O
Angptl4	O
+	O
group	O
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	B:C0025929
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	O
steatosis	I:C0015695
and	O
increased	O
serum	O
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	O
cholesterol	I:C1837784
,	O
free	O
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	O
aminotransferase	I:C0151905
and	O
aspartate	O
aminotransferase	I:C0151904
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	O
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	B:C0015695
steatosis	I:C0015695
and	O
increased	O
serum	O
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	O
cholesterol	I:C1837784
,	O
free	O
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	O
aminotransferase	I:C0151905
and	O
aspartate	O
aminotransferase	I:C0151904
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	O
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	O
steatosis	I:C0015695
and	O
increased	O
serum	B:C1287372
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	O
cholesterol	I:C1837784
,	O
free	O
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	O
aminotransferase	I:C0151905
and	O
aspartate	O
aminotransferase	I:C0151904
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	O
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	O
steatosis	I:C0015695
and	O
increased	O
serum	O
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	B:C1837784
cholesterol	I:C1837784
,	O
free	O
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	O
aminotransferase	I:C0151905
and	O
aspartate	O
aminotransferase	I:C0151904
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	O
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	O
steatosis	I:C0015695
and	O
increased	O
serum	O
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	O
cholesterol	I:C1837784
,	O
free	B:C0236060
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	O
aminotransferase	I:C0151905
and	O
aspartate	O
aminotransferase	I:C0151904
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	O
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	O
steatosis	I:C0015695
and	O
increased	O
serum	O
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	O
cholesterol	I:C1837784
,	O
free	O
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	B:C0151905
aminotransferase	I:C0151905
and	O
aspartate	O
aminotransferase	I:C0151904
.	O

Firstly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
mice	O
in	O
the	O
model	O
control	O
group	O
gained	O
more	O
body	O
weight	O
with	O
severe	O
liver	O
steatosis	I:C0015695
and	O
increased	O
serum	O
levels	I:C1287372
of	I:C1287372
triglyceride	I:C1287372
,	O
total	O
cholesterol	I:C1837784
,	O
free	O
fatty	I:C0236060
acids	I:C0236060
,	O
alanine	O
aminotransferase	I:C0151905
and	O
aspartate	B:C0151904
aminotransferase	I:C0151904
.	O

In	O
the	O
Angptl4	O
+	O
group	O
,	O
Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
reduced	O
the	O
weight	O
growth	O
rate	O
,	O
aggravated	O
hepatic	O
steatosis	I:C0015695
and	O
further	O
increased	O
all	O
the	O
aforementioned	O
serum	O
indexes	O
.	O

In	O
the	O
Angptl4	O
+	O
group	O
,	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
reduced	O
the	O
weight	O
growth	O
rate	O
,	O
aggravated	O
hepatic	B:C0015695
steatosis	I:C0015695
and	O
further	O
increased	O
all	O
the	O
aforementioned	O
serum	O
indexes	O
.	O

In	O
the	O
Angptl4	O
+	O
group	O
,	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
reduced	O
the	O
weight	O
growth	O
rate	O
,	O
aggravated	O
hepatic	O
steatosis	I:C0015695
and	O
further	O
increased	O
all	O
the	O
aforementioned	O
serum	B:C0229671
indexes	O
.	O

In	O
the	O
Angptl4	O
+	O
group	O
,	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
reduced	O
the	O
weight	O
growth	O
rate	O
,	O
aggravated	O
hepatic	O
steatosis	I:C0015695
and	O
further	O
increased	O
all	O
the	O
aforementioned	O
serum	O
indexes	B:C0600653
.	O

Secondly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
,	O
the	O
model	O
control	O
group	O
had	O
a	O
reduced	B:C0151671
glucose	I:C0151671
tolerance	I:C0151671
and	O
developed	O
insulin	O
resistance	I:C0021655
.	O

Secondly	O
,	O
compared	O
with	O
the	O
normal	O
control	O
,	O
the	O
model	O
control	O
group	O
had	O
a	O
reduced	O
glucose	I:C0151671
tolerance	I:C0151671
and	O
developed	O
insulin	B:C0021655
resistance	I:C0021655
.	O

Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	B:C1171362
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	B:C0031715
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	B:C1512804
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	B:C0017337
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	B:C1505029
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	B:C1449149
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	B:C1527619
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	B:C1530114
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	B:C0013081
in	O
the	O
liver	O
samples	I:C0586688
.	O

Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
expression	O
and	O
the	O
phosphorylation	O
levels	O
of	O
several	O
insulin	O
signaling	I:C1512804
pathway	I:C1512804
‑associated	I:C1512804
genes	O
,	O
insulin	O
receptor	I:C1505029
substrate	I:C1505029
1	I:C1505029
,	O
protein	O
kinase	I:C1449149
B	I:C1449149
,	O
janus	O
kinase	I:C1527619
2	I:C1527619
,	O
signal	O
transducer	I:C1530114
and	I:C1530114
activator	I:C1530114
of	I:C1530114
transcription	I:C1530114
3	I:C1530114
were	O
downregulated	O
in	O
the	O
liver	B:C0586688
samples	I:C0586688
.	O

Adv	B:C0001483
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
injection	O
was	O
observed	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
.	O

Adv	O
‑	O
Angiopoietin	B:C1423931
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
injection	O
was	O
observed	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
.	O

Adv	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
injection	O
was	O
observed	O
to	O
improve	B:C0184511
glucose	O
tolerance	O
and	O
insulin	O
resistance	I:C0021655
.	O

Adv	O
‑	O
Angiopoietin	O
-	I:C1423931
like	I:C1423931
protein	I:C1423931
4	I:C1423931
injection	O
was	O
observed	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	B:C0021655
resistance	I:C0021655
.	O

The	O
genes	B:C0017337
measured	O
were	O
identified	O
to	O
be	O
upregulated	O
close	O
to	O
normal	O
levels	O
.	O

The	O
genes	O
measured	O
were	O
identified	O
to	O
be	O
upregulated	B:C0041904
close	O
to	O
normal	O
levels	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	B:C1438918
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	B:C1158445
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	B:C2612213
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	B:C0025933
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	B:C0087111
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	B:C0020473
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	B:C0011847
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	B:C0524620
syndrome	I:C0524620
and	O
other	O
diseases	O
.	O

All	O
the	O
results	O
suggested	O
that	O
Angiopoietin	O
-	I:C1438918
like	I:C1438918
protein	I:C1438918
4	I:C1438918
served	O
an	O
important	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	I:C2612213
in	O
HFD	O
‑induced	I:C0025933
obese	I:C0025933
mice	I:C0025933
,	O
and	O
this	O
may	O
have	O
a	O
great	O
significance	O
for	O
treatment	O
of	O
hyperlipidemia	O
,	O
diabetes	O
,	O
metabolic	O
syndrome	I:C0524620
and	O
other	O
diseases	B:C0012634
.	O

